By computing the intersection of these machine-learning-predicted core target genes, five of them (TUBB3, JUN, EPHA2, FOS, and CDKN1C) were identified as the target hub genes of CRC treatment with LWMX pills (Figure 4g). Here, EPHA2 is linked to colorectal carcinoma.